Esculin
Latest Information Update: 25 Jun 2001
At a glance
- Originator Unknown
- Developer Nonindustrial source
- Class Antineoplastics; Coumarins
- Mechanism of Action Complement system protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 25 Jun 2001 No-Development-Reported for Cancer in Canada (Unknown route)
- 25 Jun 2001 No-Development-Reported for Cancer in USA (Unknown route)
- 25 Jun 2001 No-Development-Reported for Skin disorders in Bulgaria (Topical)